Precision Business Insights has published a report on the global blood transfusion diagnostics market, estimating its value at USD 6.09 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/blood-transfusion-diagnostics-market
The Blood Transfusion Diagnostics Market refers to the industry that focuses on diagnostic tests performed prior to blood transfusions to guarantee compatibility and safety. Blood grouping and disease screening are among the diagnostic procedures used to avoid unpleasant responses or infections. The market sells a variety of goods, including equipment, kits, and reagents, and it uses methods such as Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, and Rapid Tests. Hospitals, diagnostic laboratories, blood banks, and plasma fractionation firms are among the top end customers.
Drivers:
- Increasing Blood Donations: A rise in voluntary blood donations necessitates robust, accurate, and rapid diagnostic solutions to ensure safety and compatibility.
- Growing Organ Transplantation Procedures: The increasing number of organ transplants, which often require blood transfusions, fuels demand for advanced diagnostics.
The global blood transfusion diagnostics market segmentation:
1) By Technology: ELISA, Nucleic Acid Amplification, Rapid Test, Real-Time PCR, Fluorescence Assay, and Western Blot
2) By Product Type: Platelets, Red Blood Cells, and Albumin
3) By Application: Disease Screening, Blood Grouping, Others
4) By End User: Hospitals, Blood Banks, Diagnostic Laboratories
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=22522
Regional Overview:
The report also examines the current concerns and their Future Effects on the blood transfusion diagnostics market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the blood transfusion diagnostics market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Abbott Diagnostics, Novartis AG, Becton Dickinson, BAG Healthcare, DiaSorin, Fujirebio, Grifols, Siemens, Quidel, Hologic/Gen-Probe, Biokit, Bio-Rad, Beckman Coulter, Quotient Limited, Diagast.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
Comments
0 comment